Gastrointestinal Tumours
4 clinical trials · Condition
◉ Watch Gastrointestinal Tumours
| Record | Firm | Date |
|---|---|---|
| TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer (NCT05993702) | China Medical University, China | 2023-09-01 |
| A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients (NCT06169202) | China Medical University, China | 2023-06-01 |
| Mortality Predictions With Scorring Indices in Gastrointestinal Tumours (NCT05583292) | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | 2023-02-11 |
| Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma (NCT05461235) | China Medical University, China | 2022-07-15 |
Track Gastrointestinal Tumours automatically
Every clearance here is in the API, with alerts when new ones post.